Quick Links
About MyAmyloidosisTeam
Powered By
How Can One Get Involved In The Test Program For The Afore Mentioned New Drug
The fast-tracked amyloidosis drug, ALXN2220, is currently in phase 3 trials. To get involved in such trials, you should consult your healthcare provider or visit clinical trial registries like ClinicalTrials.gov to check for eligibility criteria and enrollment details. Always discuss with your doctor to ensure participation Show Full Answer
Will Acoramidis Replace Tafamidis If Approved In The US? Will We Have A Choice?
Anyone See Any Updated Life Expectancy With Tafamidis? Surely Someone Has Updated This Somewhere Since It Has Been In Use For Years Now
Is Anyone Taking Acoramidis (Attruby) Which Was Just Approved By The FDA And Is A Competitor To Vyndamax (tafamidis)
Sign up for free!
Continue with Facebook
Sign up with your email
